HNWAG
IMGN

High Net Worth Advisory Group’s Immunogen Inc IMGN Stock Holding History

High Net Worth Advisory Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-500
Closed -$2K – 713
2022
Q3 		$2K Buy
+500
New +$2.64K ﹤0.01% 644

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

High Net Worth Advisory Group's IMGN Position: Q4 2022 in Review

High Net Worth Advisory Group sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 500 shares — an estimated $2K sold.

High Net Worth Advisory Group first reported a position in IMGN in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

  • High Net Worth Advisory Group reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
  • High Net Worth Advisory Group sold 500 Immunogen Inc shares in Q4 2022, an estimated $2K.
  • High Net Worth Advisory Group first reported a position in Immunogen Inc in Q3 2022 and held it in 1 quarter.
  • High Net Worth Advisory Group's Immunogen Inc position peaked at $2K in Q3 2022.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on High Net Worth Advisory Group's 13F filing for Q4 2022, filed 14 Feb 2023.